Michael Kragh
Michael Kragh publishes mostly in Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, on topics such as HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research and Lung Cancer Treatments and Mutations.
- World rank
- #681,217 of 7,710,434 ranked researchers
- Rank in Denmark
- #5,115 of 43,819
- Works
- 184
- Citations
- 2.6k
- Citations per work
- 14.0
What does Michael Kragh research?
Michael Kragh's work is mostly in Medicine (64%), Biochemistry, Genetics and Molecular Biology (18%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences11864.3%
- Medicine11864.3%
- Everything else3318.2%
- Life Sciences3217.5%
- 1Oncology32% of their works
- 2Radiology, Nuclear Medicine and Imaging19% of their works
- 3Pulmonary and Respiratory Medicine10% of their works
- 4Molecular Biology10% of their works
- 5Cancer Research8% of their works
- 6Hepatology4% of their works
Research topics
Which keywords describe Michael Kragh's research?
The keywords of their largest research topics: Chemotherapy, Targeted Therapy, Breast Cancer, HER2, Fc Receptors, Therapeutic Antibodies, ALK Inhibitors and EGFR Mutations.
- endothelial progenitor cells
- VEGF
- HIF-1
- Radiopharmaceuticals
- KRAS Mutations
- EGFR Mutations
- Therapeutic Antibodies
- HER2
- Targeted Therapy
- Chemotherapy
- Breast Cancer
- Fc Receptors
- ALK Inhibitors
- Cetuximab
- PET Imaging
- Cancer Genomics
- Mutational Signatures
- Warburg Effect
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Chemotherapy582 topics
- Targeted Therapy413 topics
- Breast Cancer391 topic
- HER2391 topic
- Fc Receptors331 topic
- Therapeutic Antibodies331 topic
- ALK Inhibitors221 topic
- EGFR Mutations221 topic
- Cetuximab191 topic
- KRAS Mutations191 topic
- PET Imaging111 topic
- Radiopharmaceuticals111 topic
- Cancer Genomics81 topic
- HIF-181 topic
- Mutational Signatures81 topic
- VEGF81 topic
- Warburg Effect81 topic
- endothelial progenitor cells81 topic
Where does Michael Kragh work?
Michael Kragh's main affiliation in the publication record is Symphogen (Denmark), Denmark.
How many publications and citations does Michael Kragh have?
OpenAlex counts 184 works and 2,582 citations for Michael Kragh, an h-index of 27, ranking #681,217 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Michael Kragh. Posts are plain text and can be reported.